Deresinski S: Counterpoint: vancomycin and staphylococcus aureus--an antibiotic enters obsolescence. Clin Infect Dis. 2007, 44: 1543-1548. 10.1086/518452
Article
CAS
PubMed
Google Scholar
Allison DC, Holtom PD, Patzakis MJ, Zalavras CG: Microbiology of bone and joint infections in injecting drug abusers. Clin Orthop Relat Res. 2010, 468: 2107-2112. 10.1007/s11999-010-1271-2
Article
PubMed
PubMed Central
Google Scholar
Brook I: Microbiology and management of joint and bone infections due to anaerobic bacteria. J Orthop Sci. 2008, 13: 160-169. 10.1007/s00776-007-1207-1
Article
PubMed
Google Scholar
Lipsky BA, Weigelt JA, Gupta V, Killian A, Peng MM: Skin, soft tissue, bone, and joint infections in hospitalized patients: epidemiology and microbiological, clinical, and economic outcomes. Infect Control Hosp Epidemiol. 2007, 28: 1290-1298. 10.1086/520743
Article
PubMed
Google Scholar
Mader JT, Mohan D, Calhoun J: A practical guide to the diagnosis and management of bone and joint infections. Drugs. 1997, 54: 253-264. 10.2165/00003495-199754020-00004
Article
CAS
PubMed
Google Scholar
Sievert DM, Rudrik JT, Patel JB, McDonald LC, Wilkins MJ, Hageman JC: Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clin Infect Dis. 2008, 46: 668-674. 10.1086/527392
Article
CAS
PubMed
Google Scholar
Molin S, Tolker-Nielsen T: Gene transfer occurs with enhanced efficiency in biofilms and induces enhanced stabilisation of the biofilm structure. Curr Opin Biotechnol. 2003, 14: 255-261. 10.1016/S0958-1669(03)00036-3
Article
CAS
PubMed
Google Scholar
Nishimura S, Tsurumoto T, Yonekura A, Adachi K, Shindo H: Antimicrobial susceptibility of Staphylococcus aureus and Staphylococcus epidermidis biofilms isolated from infected total hip arthroplasty cases. J Orthop Sci. 2006, 11: 46-50. 10.1007/s00776-005-0968-7
Article
CAS
PubMed
Google Scholar
Chamberlain RS, Culshaw DL, Donovan BJ, Lamp KC: Daptomycin for the treatment of surgical site infections. Surgery. 2009, 146: 316-324. 10.1016/j.surg.2009.03.037
Article
PubMed
Google Scholar
Rice DA, Mendez-Vigo L: Daptomycin in bone and joint infections: a review of the literature. Arch Orthop Trauma Surg. 2009, 129: 1495-1504. 10.1007/s00402-008-0772-x
Article
PubMed
PubMed Central
Google Scholar
Traunmuller F, Schintler MV, Metzler J, Spendel S, Mauric O, Popovic M, Konz KH, Scharnagl E, Joukhadar C: Soft tissue and bone penetration abilities of daptomycin in diabetic patients with bacterial foot infections. J Antimicrob Chemother. 2010, 65: 1252-1257. 10.1093/jac/dkq109
Article
PubMed
Google Scholar
Julian BA, Quarles LD, Niemann KM: Musculoskeletal complications after renal transplantation: pathogenesis and treatment. Am J Kidney Dis. 1992, 19: 99-120.
Article
CAS
PubMed
Google Scholar
Sprague SM: Mechanism of transplantation-associated bone loss. Pediatr Nephrol. 2000, 14: 650-653. 10.1007/s004670000359
Article
CAS
PubMed
Google Scholar
Wang EH, Simpson S, Bennet GC: Osteomyelitis of the calcaneum. J Bone Joint Surg Br. 1992, 74: 906-909.
CAS
PubMed
Google Scholar
Mersebach H, Johansson JO, Rasmussen AK, Bengtsson BA, Rosenberg K, Hasholt L, Sorensen SA, Sorensen SS, Feldt-Rasmussen U: Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density. Genet Med. 2007, 9: 812-818. 10.1097/GIM.0b013e31815cb197
Article
CAS
PubMed
Google Scholar
Hiramatsu K: Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis. 2001, 1: 147-155. 10.1016/S1473-3099(01)00091-3
Article
CAS
PubMed
Google Scholar
Garazzino S, Aprato A, Baietto L, D'Avolio A, Maiello A, De Rosa FG, Aloj D, Siccardi M, Biasibetti A, Masse A, Di Perri G: Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibia. Clin Pharmacokinet. 2008, 47: 793-805. 10.2165/0003088-200847120-00004
Article
CAS
PubMed
Google Scholar
Norden CW, Shaffer M: Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with vancomycin and rifampin. J Infect Dis. 1983, 147: 352-357. 10.1093/infdis/147.2.352
Article
CAS
PubMed
Google Scholar
Lodise TP, Lomaestro B, Graves J, Drusano GL: Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob Agents Chemother. 2008, 52: 1330-1336. 10.1128/AAC.01602-07
Article
CAS
PubMed
PubMed Central
Google Scholar
Di Paolo A, Malacarne P, Guidotti E, Danesi R, Del Tacca M: Pharmacological issues of linezolid: an updated critical review. Clin Pharmacokinet. 2010, 49: 439-447. 10.2165/11319960-000000000-00000
Article
CAS
PubMed
Google Scholar
Garcia-de-la-Maria C, Marco F, Armero Y, Soy D, Moreno A, del Rio A, Almela M, Cervera C, Ninot S, Falces C, Mestres CA, Gatell JM, Jiménez de Anta MT, Miró JM, Hospital Clínic Experimental Endocarditis Study Group: Daptomycin is effective for treatment of experimental endocarditis due to methicillinresistant and glycopeptide-intermediate Staphylococcus epidermidis. Antimicrob Agents Chemother. 2010, 54: 2781-2786. 10.1128/AAC.01011-09
Article
CAS
PubMed
PubMed Central
Google Scholar
Chaftari AM, Hachem R, Mulanovich V, Chemaly RF, Adachi J, Jacobson K, Jiang Y, Raad I: Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents. 2010, 36: 182-186. 10.1016/j.ijantimicag.2010.03.015
Article
CAS
PubMed
Google Scholar
Sader HS, Farrell DJ, Jones RN: Antimicrobial susceptibility of Gram-positive cocci isolated from skin and skin-structure infections in European medical centres. Int J Antimicrob Agents. 2010, 36: 28-32. 10.1016/j.ijantimicag.2010.03.016
Article
CAS
PubMed
Google Scholar
Burkhardt O, Kielstein JT: A simplified three-times weekly daptomycin dosing regimen for chronic hemodialysis patients. Expert Rev Anti Infect Ther. 2010, 8: 11-14. 10.1586/eri.09.121
Article
CAS
PubMed
Google Scholar
Kielstein JT, Eugbers C, Bode-Boeger SM, Martens-Lobenhoffer J, Haller H, Joukhadar C, Traunmüller F, Knitsch W, Hafer C, Burkhardt O: Dosing of daptomycin in intensive care unit patients with acute kidney injury undergoing extended dialysis-a pharmacokinetic study. Nephrol Dial Transplant. 2010, 25: 1537-1541. 10.1093/ndt/gfp704
Article
CAS
PubMed
Google Scholar
Lamp KC, Friedrich LV, Mendez-Vigo L, Russo R: Clinical experience with daptomycin for the treatment of patients with osteomyelitis. Am J Med. 2007, 120: S13-S20.
Article
CAS
PubMed
Google Scholar
Bassetti M, Nicco E, Ginocchio F, Ansaldi F, de Florentiis D, Viscoli C: High-dose daptomycin in documented Staphylococcus aureus infections. Int J Antimicrob Agents. 2010, 36: 459-461. 10.1016/j.ijantimicag.2010.07.011
Article
CAS
PubMed
Google Scholar
Seaton RA: Daptomycin: rationale and role in the management of skin and soft tissue infections. J Antimicrob Chemother. 2008, 62 (Suppl 3): 15-23.
Google Scholar